219 related articles for article (PubMed ID: 21995493)
1. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X; Liao Z; Ma H; Qian J; Liu Z; Yuan X; Gomez D; Komaki R; Wang LE; Wei Q
BMC Cancer; 2011 Oct; 11():447. PubMed ID: 21995493
[TBL] [Abstract][Full Text] [Related]
2. Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.
Guo Y; Feng Y; Liu H; Luo S; Clarke JW; Moorman PG; Su L; Shen S; Christiani DC; Wei Q
Mol Carcinog; 2019 Jul; 58(7):1094-1104. PubMed ID: 30989732
[TBL] [Abstract][Full Text] [Related]
3. Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.
Xu F; Zhou G; Han S; Yuan W; Chen S; Fu Z; Li D; Zhang H; Li D; Pang D
PLoS One; 2014; 9(7):e101138. PubMed ID: 25010932
[TBL] [Abstract][Full Text] [Related]
4. Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy.
Wang TL; Song YQ; Ren YW; Zhou BS; Wang HT; Bai L; Zhang HB; Yu H; Zhao YX
Clin Lab; 2016; 62(3):301-10. PubMed ID: 27156317
[TBL] [Abstract][Full Text] [Related]
5. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.
Chen W; Xu H; Wang X; Gu J; Xiong H; Shi Y
Int Immunopharmacol; 2015 Sep; 28(1):146-53. PubMed ID: 26071216
[TBL] [Abstract][Full Text] [Related]
6. Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
Guan X; Yin M; Wei Q; Zhao H; Liu Z; Wang LE; Yuan X; O'Reilly MS; Komaki R; Liao Z
BMC Cancer; 2010 Aug; 10():431. PubMed ID: 20712888
[TBL] [Abstract][Full Text] [Related]
7. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
[TBL] [Abstract][Full Text] [Related]
8. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
11. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
Ma H; Chen J; Pan S; Dai J; Jin G; Hu Z; Shen H; Shu Y
Lung Cancer; 2011 Jul; 73(1):32-7. PubMed ID: 21145615
[TBL] [Abstract][Full Text] [Related]
12. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.
Xu T; Wei Q; Lopez Guerra JL; Wang LE; Liu Z; Gomez D; O'Reilly M; Lin SH; Zhuang Y; Levy LB; Mohan R; Zhou H; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e229-35. PubMed ID: 22608953
[TBL] [Abstract][Full Text] [Related]
13. TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Kuwahara A; Yamamori M; Fujita M; Okuno T; Tamura T; Kadoyama K; Okamura N; Nakamura T; Sakaeda T
J Exp Clin Cancer Res; 2010 Jul; 29(1):100. PubMed ID: 20646319
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
Bi N; Yang M; Zhang L; Chen X; Ji W; Ou G; Lin D; Wang L
Clin Cancer Res; 2010 Apr; 16(8):2383-90. PubMed ID: 20332326
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
17. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Bergamino M; Rullan AJ; Saigí M; Peiró I; Montanya E; Palmero R; Ruffinelli JC; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Cardenal F; Nadal E
BMC Cancer; 2019 Feb; 19(1):165. PubMed ID: 30791870
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
Wen J; Liu H; Wang Q; Liu Z; Li Y; Xiong H; Xu T; Li P; Wang LE; Gomez DR; Mohan R; Komaki R; Liao Z; Wei Q
Eur J Cancer; 2014 Jul; 50(10):1706-1716. PubMed ID: 24780874
[TBL] [Abstract][Full Text] [Related]
19. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.
Xu JL; Hu LM; Huang MD; Zhao W; Yin YM; Hu ZB; Ma HX; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):851-6. PubMed ID: 22631660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
